Ingredient record · Blood thinner (antiplatelet)
Clopidogrel: bans, restrictions and failed batches in India
Last checked 20 September 2026. Sources: CDSCO banned-drugs notifications and monthly NSQ alerts, Jan 2019 to Jul 2026
2 entries containing Clopidogrel are on India's banned-drugs list, and 0 are banned today. 51 batches of medicines containing Clopidogrel failed a government lab test between February 2019 and July 2026, from 33 manufacturers. A failed batch concerns that batch only, not the medicine or every brand.
0
Banned combinations in force
2
Other listed orders (stayed, restricted, quashed)
51
Batches failed a lab test
Jul 2026
Latest lab alert
On the banned-drugs list
Clopidogrel on its own is not on CDSCO's banned list. The entries below are specific combinations that contain it. Status follows CDSCO's own notes on each entry.
| Drug / combination | Action | Notification | Date | Order | Status note |
|---|---|---|---|---|---|
| Rosuvastatin 20mg + Clopidogrel 75mg + Aspirin 150mg (Gastro-Resistant) CapsuleFixed-dose combination · cardiac | Halted | CDSCO F.No. 4-01/2023-DC (Misc. 3) dated 11.04.2025, Annexure Sr. 18 | 11 April 2025 | 35 FDCs · Apr 2025 | CDSCO direction to state licensing authorities, 11 Apr 2025, not a Section 26A gazette ban |
| Rosuvastatin 10mg + Clopidogrel 75mg + Aspirin 150mg (Gastro-Resistant) CapsuleFixed-dose combination · cardiac | Halted | CDSCO F.No. 4-01/2023-DC (Misc. 3) dated 11.04.2025, Annexure Sr. 19 | 11 April 2025 | 35 FDCs · Apr 2025 | CDSCO direction to state licensing authorities, 11 Apr 2025, not a Section 26A gazette ban |
Products that failed lab tests
Product names as printed by the testing labs, grouped. Open a product to see every batch number.
| Product | Batches | Makers | Latest |
|---|---|---|---|
| Clopidogrel Aspirin | 25 | 16 | Jul 2026 |
| Clopidogrel | 11 | 7 | May 2026 |
| Atorvastatin Clopidogrel | 4 | 4 | Jul 2026 |
| Rosuvastatin Aspirin Clopidogrel | 4 | 3 | May 2026 |
| Atorvastatin Aspirin Clopidogrel S | 1 | 1 | Feb 2026 |
| Clopimen Clopidogrel | 1 | 1 | Sep 2025 |
| Clopiras Clopidogrel Bisulphate | 1 | 1 | Jul 2025 |
| Clorin | 1 | 1 | Jun 2023 |
| Pilogrel A | 1 | 1 | Oct 2022 |
| Clopitab | 1 | 1 | Feb 2021 |
| Clopican A | 1 | 1 | May 2019 |
Most recent failed batches
| Product | Batch | Manufacturer | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|---|
| Clopidogrel & Aspirin Tablets IP | P0825176TMfg 2025-08 · Exp 2027-07 | Pharmaroots HealthcareHimachal Pradesh | Dissolution, Free Salicylic Acid, Content of Clopidogrel (38.20%) and Aspirin (21.8%)Dissolution | Drugs Testing Laboratory, Chennai-06State lab | Jul 2026 |
| Clopidogrel & Aspirin Tablets | TSF-C2763Mfg 2024-10 · Exp 2026-09 | Spen Formulations Pvt. Ltd | DescriptionDescription | Drugs Testing Laboratory, Chennai-06State lab | Jul 2026 |
| Clopidogrel & Aspirin Tablets | GT31923CMfg 2026-02 · Exp 2028-01 | J.M. LaboratoriesHimachal Pradesh | Free salicylic Acid (12.01%) and Content of Aspirin (77.13%)Other | Drugs Testing Laboratory, Chennai-06State lab | Jul 2026 |
| Atorvastatin and Clopidogrel Tablets | PGT25-3110AMfg 2025-11 · Exp 2027-10 | Plena RemediesHimachal Pradesh | Does not conform to required standards with respect to the test AssayAssay | Food & Drugs Laboratory Bambolim, GoaState lab | Jul 2026 |
| Rosuvastatin, Aspirin and Clopidogrel Capsules | SIBP25509Mfg 2025-08 · Exp 2027-07 | Bioaltus Pharmaceuticals Pvt. LtdSikkim | The sample does not conform to the claim with respect to Assay of Rosuvastatin and Aspirin.Assay | DTL JaipurState lab | May 2026 |
| Clopidogrel and Aspirin Capsules | ND260242Mfg 2026-01 · Exp 2027-12 | Nanoceut Therapeutics Pvt. LtdPuducherry | Free Salicylic acidOther | DTL, Chennai-06State lab | May 2026 |
| Clopidogrel Tablets IP | BCGT25020Mfg 2025-06 · Exp 2027-05 | Bactolac Formulations Pvt. LtdTelangana | Content & DissolutionDissolution | DTL, Chennai-06State lab | May 2026 |
| Clopidogrel Tablets IP | BCGT25021Mfg 2025-06 · Exp 2027-05 | Bactolac Formulations Pvt. LtdTelangana | DescriptionDescription | DTL, Chennai-06State lab | Feb 2026 |
| Atorvastatin, Aspirin & Clopidogrel Capsules s | ADH24148AMfg 2024-10 · Exp 2026-09 | Astonea Labs Pvt. LtdHaryana | Test free Salycylic AcidOther | MaharashtraState lab | Feb 2026 |
| Clopidogrel Tablets IP 75 mg | T-2405315Mfg 2024-05 · Exp 2026-04 | Rivpra Formulation Pvt. LtdUttarakhand | The sample received does not conform to IP 2022 specification with respect to the Description only.Description | CDTL, HyderabadCDSCO lab | Jan 2026 |
| Clopidogrel Tablets IP | BCGT25042Mfg 2025-07 · Exp 2027-06 | Bactolac Formulations Pvt. LtdTelangana | DescriptionDescription | Drugs Testing Laboratory, Chennai-06State lab | Jan 2026 |
| Clopidogrel Tablets IP | BCGT25048Mfg 2025-07 · Exp 2027-06 | Bactolac Formulations Pvt. LtdTelangana | DescriptionDescription | Drugs Testing Laboratory, Chennai-06State lab | Jan 2026 |
| Clopidogrel Tablets IP | BCGT25049Mfg 2025-07 · Exp 2027-06 | Bactolac Formulations Pvt. LtdTelangana | DescriptionDescription | Drugs Testing Laboratory, Chennai-06State lab | Jan 2026 |
| Clopidogrel & Aspirin Tablets IP | GT250518Mfg 2025-03 · Exp 2027-02 | Theon Pharmaceuticals LtdHimachal Pradesh | The sample Received Does Not Conform To I.P. 2022 Specification With Respect To The Description And Test For Free Salicylic Acid Only.Description | CDTL-HyderabadCDSCO lab | Dec 2025 |
| Clopidogrel & Aspirin Tablets IP | GT250519Mfg 2025-03 · Exp 2027-02 | Theon Pharmaceuticals LtdHimachal Pradesh | The sample Received Does Not Conform To I.P. 2022 Specification With Respect To The Description And Test For Free Salicylic Acid Only.Description | CDTL-HyderabadCDSCO lab | Dec 2025 |
Showing 15 of 51 records
Holding a strip or bottle? The batch number is printed after "B. No." Check it against every alert. If it matches, return it to the pharmacy. What the labels mean: status guide.